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In this chapter, the usual practice has been omi tted of 
devoting a section to historical background. The reason is that 
the first report by C. S. Welch of whole-organ hepatic transptan-
tation in dogs was only 28 years ago. Furthermore, the first 
clinical attempts at liver transplantation were not described 
until 1963 • Consequently, these as well as most of the other 
early articles on liver transplantation are still of current 
interest. 
Until recently Ii vel' transplantation was considered an ex-
perimental operation. At a Consensus Development Conference held 
in Bethesda, Maryland on June 20-23, 1983, under the sponsorship 
of several federal agenc i es, the adjud i ca ti on was made that the 
operation had become therapeutic. With this change in classifi-
cation, it is certain that a number of new liver transplantation 
centers will spring up in the United States in the next year or 
two. Thus, for the first time liver transplantation will become 
an acknowledged part of the surgical armamentarium available for 
the treatment of end stage hepatic disease. 
KINDS OF OPERATIONS 
Auxiliary Transplantation 
There are two general approaches to transplantation of the 
liver. With one method, an extra liver is inserted at an ectopic 
site, without removal of the diseased native organ. This was a 
procedure that Welch envisioned wi th the ultima te objecti ve of 
treating patients who were dying of cirrhosis or other non-neo-
plastic hepatic diseases. 
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One technique used for auxiliary hepatic transplantation as 
adapted to human subjects is depicted in Figure 1. Here, the 
• 
extra liver is placed in the right paravertebral gutter or right 
pelvis. Its hepatic arterial supply is derived from the aorta or 
an iliac artery. Venous inflow is reconstituted by anastomosing 
the host superior mesenteric vein to the homograft portal vein. 
Outflow is into the inferior vena cava. 
At first thought, the use of auxiliary homografts for the 
treatment of benign hepatic disease has a special appeal. First, 
sacrifice of the remaining, albeit limited, function of the 
ailing recipient liver can be avoided. Thus, in the event of 
'I 
poor initial performance by the homograft due to ischemia or to a 
severe but reversible rejection, it might be hoped that some 
assistance would be provided by the diseased host liver during a 
transi tion recovery period. This would be predicted to be a 
particularly significant advantage in patients with biliary atre-
s i a, since the synthes i zi ng funct ions of the 1 i ver are often 
retained until the terminal stages of this disease. Second, it 
was assumed initially that the placement of an extra liver would 
be safer and technically less demanding than the orthotopic pro-
cedure. 
In actual practice, auxiliary transplantation has lost much 
favor. The results in animals have been inferior to those with 
liver replacement, partly because coexisting livers have the 
, 
capacity to damage each other to a variable degree, according to 
which organ is the "dominant" one. Factors favoring dominance 
include a splanchnic source of the blood for portal venous in-
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flow, perfect biliary drainage, optimal total hepatic blood flow, 
• 
and unimpeded venous outflow. An auxiliary canine liver graft, 
which does not enjoy these advantages relative to the host liver, 
undergoes rapid atrophy by mechanisms that have been ascribed to 
"interliver competition." A detailed discussion of this fascina-
ting topic (often referred to as hepatotrophic physiology) can be 
found in other texts. 
1 
Here, it will only be noted that most patients who would be 
candidates for liver transplantation do not have adequately func-
tioning li vers, so that the concept of competi tion may not be a 
critical one in clinical practice. Nevertheless, auxiliary liver 
transplantation for the indication of hepatic failure has resul-
ted in the significant prolongation of life for only two pa-
tients. One was a child with biliary atresia who is still well 
as of August 1983, more than 10 1/2 years after auxiliary 
transplantation by Fortner, of New York, using a technique 
similar to that shown in Figure 1. The second patient, an adult, 
treated in Paris had lived for more than 2 years at the time of 
his reporting in May, 1980. 
The reasons for failure in the vast majority of patients 
have been several. In many cases good inital homograft function 
was not obtained due to an ischemic injury during and/or after 
donor death. In others, the presence of an extra organ wi thin 
the abdomen was not well tolerated with restriction of diaphrag-
matic movement and consequent lethal pulmonary complications. 
Finally, the expectation that the placement of an extra organ 
would be technically simpler than with liver replacement has not 
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been borne out by actual experience, as evidenced by an extremely 
high incidence of mechanical complications. Because of the poor 
• 
clinical results, the number of attempts at human auxiliary 
transplantation has declined to the point that this kind of oper-
ation will not be considered further in the rest of the chapter. 
Orthotopic Transplantation 
In contrast, there is mounting evidence that the operation 
of orthotopic hepatic transplantation (liver replacement) will 
play an increasing role in the future treatment of liver disor-
ders. Wi th this procedure, the diseased host Ii ver is removed, 
creating a space into which a graft is transplanted with as nor-
mal an anatomic reconstruction as possible. Survival in dogs and 
human subjects has been achieved exceeding 12 and 13 2/3 years, 
respectively. The remarks in suceeding sections will pertain to 
orthotopic transplantation. 
PREOPERATIVE PREPARATION 
Virtually all prospective liver recipients are poor risks 
for a major operation, and many of those with hepatic failure 
from non-neoplastic diseases appear at first evaluation to be 
hopeless. Symptomatic relief may be obtained by the performance 
of procedures such as paracentesis or thoracocentesis. But, 
unfortunately, there is probably little of real value that can be 
done to reduce the consequent operative hazards short of provi-
ding liver tissue. Nevertheless, even patients near death from 
complicaeions of hepatic disease can be brought through the 
transplantation procedure with almost immediate improvement pro-
viding the homograft functions properly and promptly. 
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Although little can be done for the preexisting liver fail-
ure; secondary abnormali ties of other organs can sometimes be 
• 
effectively ameliorated. For example, the effects of renal fail-
ure secondary to the hepatorenal syndrome can be treated with the 
artificial kidney. Pulmonary manifestations may be improved by 
simple tracheobronchial toilet, particularly if aspiration has 
occurred. Transfusions of blood or albumin may be useful for the 
correction of blood volume or other fluid space abnormali ties. 
If fresh whole blood, fresh frozen plasma, or platelets are ju-
diciously given, some improvement in coagulation may be possible. 
CASE SELECTION 
Of the 237 patients treated from 1 March 1963 through April 
1982, 112 were classed as pediatric recipients (Table 1); their 
ages ranged from 5 months to 18 years. The 125 adults (Table 2) 
were 19 to 68 years old. 
It is now clear that none of the disorders for which trans-
plantation has been attempted can be excluded categorically from 
future trials. At the same time, a fairly complete understanding 
has evolved with many specific diseases about what advice to give 
to prospective recipients and their families, when and if the 
operation should be decided upon, how much risk there is of de-
terioration and death during the search for a donor organ, and 
what are the technical difficulties to be anticipated during the 
transplantation. 
At 'present, candidacy is restricted to patients who are less 
than 55 years old, who are free of extrahepatic infection, and 
who do not have an extrahepatic malignancy. Within this group, 
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the 2 rna in pr i nc i pI es incase se lec t i on concern, fi rst the pro-
pri ety of a dec i s i on to procede and, second, the feas i b iIi ty of 
• an attempt. In the early days of transplantation, the propriety 
issue was the dominant theme because of anxiety that meaningful 
life might be foreshortened by a dangerous and unpredictable 
surgical undertaking. Our general guideline was that transplan-
ta t i on for non-neoplast i c 1 i ver disease became jus t i fiable with 
the advent of social and vocational invalidism. This condi tion 
usually was reflected in repeated hospitalizations for encephalo-
pathy, variceal hemorrhage, hepatorenal syndrome, uncontrolled 
coagul at i on disorders, i ntrac t i ble asci tes and other compl i ca-
tions of hepatic disease. 0' 
According to Underlying Diseases 
Hepatic Malignancy - - - When orthotopic liver transplanta-
tion was first attempted in humans, primary liver malignancy was 
considered to be an outstanding indication for proceeding. Liver 
replacement was conceived of as a means of extending the limits 
of resectability in patients who did not have extrahepatic spread 
of their tumors. 
In actual experience our resul ts in our early cases were 
discouraging. About 80 percent of our patients who had liver 
replacement for hepatomas, intrahepatic duct cell carcinomas, 
cholangiocarcinomas, and sarcomas and who lived through the early 
postoperative interval developed tumor recurrence. Most com-
monly, the posttransplantation metastases involved the new liver 
(Figure 2). Deaths from recurrence have ocurred as early as 143 
days (Figure 2) and longer than 4 years after transplantation. 
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It is too early to conclude once and for all that Ii ver 
• 
replacement in the face of hepatic malignancy is a futile under-
taking. One of our patients, whose primary reason for liver 
transplantation was biliary atresia, had an incidental hepatoma 
in the total hepatectomy specimen. Her preoperative serum con-
tained almost 4 mg per dl of alpha fetoprotein. After operation 
in January 1970, the fetoprotein disappeared from the serum (Fig-
ure 3) and has not recurred in the 13 2/3 years of posttransplan-
tation life. Apparently, this child has achieved a cure from her 
hepatoma. Another of our patients, a 28-year-old woman, is well 
6 3/4 years after transplantation for sclerosing cholangiocarcin-
oma. Palliation or even cure of primary hepatic malignancies has 
also been reported by CaIne. 
Since immunosuppress ion wi th cyclosporine and steroids has 
been used, the incidence of recurrence has been much less. This 
may only reflect better case selection. However, it cannot be 
assumed out of hand that cyclosporine dose not have some antican-
cer qualities. 
Biliary Atresia - - - Nevertheless, the prime indications 
for orthotopic Ii ver transplantation have come to be terminal 
liver diseases of non-neoplastic origin. Of these, extrahepatic 
biliary atresia is perhaps the least questionable, since death is 
inevitable after a relatively predictable interval and without 
any hope in the remaining life for rehabilitation. Wi th intra-
hepatic biliary atresia, more conservatism is exercised, since 
some of these children can survive for many years. 
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Other Benign Diseases - - -The problem of the proper time 
for liver transplantation may be a difficult one if alcoholism is 
• a significant etiologic factor that could be eliminated by ab-
stinence. Other common disease in our series (Tables 1 and 2) 
have been chronic aggressive hepatitis, inborn errors of metabo-
1 ism ( W i 1 son's dis e a s e , alp h a - 1 - ant i try psi n de f i c i en c y , T Y P es 1 
'-
and 4 glycogen storage disease, tyrosinemia, sea blue histiocyte 
syndrome), sclerosing cholangi tis, and primary biliary cirrho-
sis. Patients with acute liver disease usually are not con-
sidered since they may have the capacity to recover spontaneous-
ly. Contraindications would include advanced age, a history of 
sociopathic behavior that would prevent postoperative management, 
preexisting and untreatable systemic or local infections, or 
serious disease of organs other than the liver, as, for example, 
coexisting severe heart disease. 
According to Immunologic Criteria 
ABO Matching and Cytotoxic Antibodies - - - When possible, 
the rules of tissue transfer are followed (Table 3). These are 
designed to avoid the transplantation of an organ into a recip-
ient who possesses preformed antidonor isoagglutinins. Violation 
of these guidelines in kidney transplantation can lead to immedi-
ate graft destruction by hyperacute rejection. The Ii ver has 
proved resistant to this complication, meaning that blood group 
barriers can be breached in the case of desperate need. Even 
more surprisingly, the presence of preformed cytotoxic antibodies 
against donor tissues does not usually cause hyperacute Ii ver 
rejection. 
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HL-A Matching - - - The poor correlation in renal, cardiac, 
and 1 i ver transplant a t i on between rna tch i ng at the A, B, and Dr 
• histocompatibility loci and clinical outcome has led us to ignore 
the question of tissue matching for Ii ver transplantation. Nor 
do we even use the most favorable matching as an instrument of 
selection amongst a gi ven group of cand i da tes for transplanta-
tion. At the present, our major criterion concerns who has the 
most pressing need. 
DONOR PROCUREMENT 
The most common explanation for transplantation of an in-
adequately preserved liver is pre-existing hepatic injury, rather 
than poor harvesting or preservation'technique. Thus, removal of 
a satisfactory liver for transplantation begins with wise scree-
ning of donors and elimination of those whose physiologic situa-
tion could jeopardize vital organ function in advance of procure-
ment. As i de from abnormal i ties in the hepa tic funct i on prof i le, 
signals that it may be dangerous to the recipient to procede with 
the donor hepatectomy are donor card iovascular instabi 1 i ty, a 
need for excessive vasopressor support, an excessive period (sev-
eral days) between injury and the pronouncement of brain death, 
or the deterioration of renal function which may suggest poor 
perfusion of other organs. 
OPERATIVE PROCEDURES 
The Donor Operation 
Initial ~issection - A midline sternotomy and celiotomy ex-
tending from the sternal notch to the pubic symphysis provides 
excellent exposure not only of the liver but of the kidneys and 
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other organs which might be needed. After assessing the liver 
and other organs for gross suitability, anomalies of the hepatic 
arterial supply are looked for (Figure 4). • A common variant is 
an artery to the left lateral segment arising from the left gas-
tric artery. It can be found coursing from left to right in the 
gastro-hepatic ligament accompanied by fibers from the vagus 
nerve. This vessel can be preserved in continuity with its left 
gastric origin and the celiac axis. 
The right lobe of the liver (and sometimes the entire liver) 
\ 
may be supplied by a branch from the superior mesenteric artery 
(Figure 4). Almost invariably this branch lies posterior to the 
portal vei n and can be fel t there wi th a fi nger placed through 
the foramen of Winslow (Figure 5A). On rare occasions, in which 
the left gastric or superior mesenteric artery branches supply 
the entire liver, a true common hepatic artery arising from the 
celiac axis may not be found. 
After the anomalies have been identified, the structures of 
the portal triad are dissected, staying as far from the liver as 
possible. Usually, the hepatic artery is dissected retrograde, 
starting with ligation and division of the gastro-duodenal and 
right gastric arteries (Figure 5). The splenic and left gastric 
(and sometimes phrenic) branches of the celiac axis are ligated 
and divided. The proximal dissection is facilitated by cutting 
the d iaphragma tic crura, expos ing the or i g in of the cel i ac ax is 
and a short segment of the subdiaphragmatic aorta. If a good 
view of the common hepatic artery, the celiac axis and the aorta 
cannot be obtained easily with this anterior approach, the spleen 
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and stomach can be mobilized and reflected to the right, and the 
aorta is approached from the left side (Figure 6). At some time 
• during the dissection, the origin of the superior mesenteric 
artery is also exposed so that it can be ligated later. 
An anomalous superior mesenteric artery branch to the right 
hepatic lobe (occasionally it is the sole arterial supply of the 
li ver) is best approached by performing a Kocher maneuver and 
reflecting the duodenum and head of the pancreas to the left. 
The hepatic artery (Figure 4) can be seen posterior to the portal 
vein, duodenum and pancreas and traced back to its take off which 
is at a right angle from the superior mesenteric artery. Small 
branches to the pancreas are ligated and divided. The super i or 
mesenteric artery distal to its hepatic branch is dissected so 
that later ligation is possible. The superior mesenteric artery 
proximal to this point is cleaned back to its origin from the 
aorta. This may be most easily done from the left side (Figure 
6) or from an inferior approach. 
Having completed the dissection of the arterial supply, the 
portal vein is isolated at the superior border of the pancreas. 
The pancreas can be divided at this level between two mass liga-
tures and exposure of adequate lengths of splenic and superior 
mesenteric veins obtained. All other branches to the portal vein 
are 1 i ga ted or d i v i ded, the most constant be ing coronary ve i ns 
(Figure 5). 
The'common bile duct is encircled as close to the superior 
marg in of the duodenum as poss i ble. A transverse inc is i on is 
made high on the fundus of the gallbladder and the extrahepatic 
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biliary tract flushed out with saline to prevent later autolysis 
of the mucosa by bile. 
• It remains to dissect the inferior vena cava. The falci-
form, left and ri gh t tr i angular, and coronary 1 i gamen ts are di-
vided and the suprahepatic vena cava is encircled (Figures 7-
9). Care is taken to identify, ligate and divide the right, left 
and posterior phrenic veins. The right lobe is retracted antero-
medially and the retrohepatic vena cava is dissected free to the 
level of the renal vein inferiorly (Figure 9). This step re-
quires ligation and division of a large right adrenal vein and 
occasionally smaller tributaries. 
'i In some cases, retraction of the liver from the liver fossa 
causes color changes in the organ reflecting ei ther inflow or 
outflow obstruction. If the donor mean arterial pressure falls, 
the cause usually is outflow obstruction with compromised cardiac 
filling fl~om loss of venous return. In such an event, retro-
hepatic vena caval dissection is deferred until the final steps. 
Our present policy is to carry out in _si tu infusion of the 
kidneys and liver, although many surgeons with whom we collabor-
ate prefer to excise the kidneys at this time and to flush them 
ex-vivo. With either method for the kidney removal, the princi-
pIes of the hepatectomy are the same. The donor is anti-coagu-
lated with heparin (300 USP units per kg.) and a large cannula is 
inserted into the distal aorta near the bi furcation to provide 
for in situ infusion of cold (4 0 C) preservation solution (Figure 
10). A second cannula is placed i!1to the distal vena cava to 
allow bleeding off of central venous volume during the subsequent 
infusion of cold solutions (Figure 10). 
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Precooling of the Liver 
A critical principle in the procurement of satisfactory 
• livers is to bring the infusion of cold solution into the portal 
vein while there is still an effective donor circulation. This 
step of hepatic precooling eliminates warm ischemia by reducing 
the temperature of the liver- tissue while an adequate flow of 
oxygenated arterial blood is still present. At the same time, 
added protection to the kidney and other organs is provided since 
donor core temperatures during this precooling phase drift quick-
ly to 28-32 0 C at the same time as the Ii ver temperature drops 
several degrees below this. 
The precool i ng sol u ti on is i n tl~oduced into the portal ve in 
via a cannula inserted into the previously dissected splenic vein 
(Figure 10). Col d ( 40 C ) 1 act ate d R i n g e r 's sol uti 0 n i s l' a p i d 1 Y 
infused and dur i ng the in fus i on the super ior roes enter i c ar tery 
and vein are ligated in that order. Perfusion pressures of 80-
100 em of water are maintained by elevation of the infusion res-
ervoir. Central venous hypertension is avoided by intermittently 
bleeding off blood volume via the previously placed inferior vena 
ca va cannula. After approximately a liter of lactated Ringer's 
soluti on has been infused, the 1 i ver becomes noti ceably cool to 
palpation. Any increased firmness of the organ suggests hepatic 
venous hypertens i on and demands i mmed i ate lower i ng of cent ral 
venous pressures by bleeding off from the caval cannula and slo-
wing of the portal infusion. The infusion is continued until a 
total of approx ir:a te 1y 2000 ml of J acta ted Ringer's have been 
given, until donor core temperature reaches 28-30 0 C, or until 
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there is difficulty maintaining the donor blood pressure. During 
the precooling, a vasolytic agent (e.g. chlorpromazine, phentola-
• 
mine, tolazoline) is given as an intravenous bolus injection. 
Final sta~ 
As portal precoolil1g is terminated, _~!:!K _situ aortic flushing 
of the liver, kidneys, or other organs is begun (Figure 10). The 
abdominal aorta is clamped at the diaphragm and rapid infusion of 
cold (4 0 C) modified Collin's solution (TravenoI R) is begun via 
the distal aortic cannula at the same time as the vena cava can-
nula is opened to allow free drainage of blood to a collection 
bag placed on the floor. The portal vein infusion of lactated 
Ringer's solution is changed to a modified Collin's solution 
(TravenoIR) for a final flush in adult donors of about 500 ml or 
of a proportionately smaller a~ount in pediatric donors. 
All of the abdominal organs are now cold. The Ii ver is 
removed first. The suprahepatic vena cava is transected as high 
as possible (Figure 11). A piece of the right atrium sometimes 
is included. The liver is peeled out from the retroperitoneum 
from a superior to inferior direction by gentle anterior traction 
on the liver, care being taken to ligate all posterior tributa-
ries to the retrohepatic vena cava. The vena cava is transected 
just superior to the entrance of the renal veins. The aorta is 
re-clamped just distal to the celiac axis so that further infu-
, 
sion of the kidneys may be continued if desired. The liver is 
removed. 
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The nephrectomy team proceeds with removal of the kidneys. 
The most common practice is to remove the organs en bloc with a 
• long segment of aorta and vena cava. The early function of cada-
ver i c kidneys obta i ned dur i ng heart and Ii ver procuremen t , or 
both heart and liver, has been better than that achieved in our 
center and elsewhere with renal procurement alone. This advan-
tage for the eventual renal recipients probably is due to the 
more discriminating donor selection and the greater intensity of 
surgical technical care that are features of the multiple organ 
harvesting operations. It should be specifically noted that 
heart and liver grafts can be obtained from the same donor with 
minor modifications of the describ~~ technique. 
The chilled liver is placed in a plastic bag that contains 
Collin's solution. The bag is sealed and packed in ice in a 
s tan d a I'd pic n i c ref rig era tor. Ca:1 i ne 1 i vers so proce ss ed can 
support the life of a recipient after storage for 12 to 24 hours 
but in 11Umans, an effort is made to keep the cold preserva ti on 
time to less than 6 or 8 hours. Using a different infusion 
solution, the Cambridge workers have described similar time 
limitations. 
Contingency Vascular Grafts 
After the organs are out, the distal aorta and vena cava, 
the iIi ac ve ins, and the iliac arter i es are removed and stored 
separa tely in bal anced electrolyte sol uti on. It is surprising 
how often these vascular segments have been desperately needed 
for the subsequent performance of a renal or hepatic transplanta-
tion (Figure 12). 
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The Recipient Operation 
• A bilateral subcostal incision is used with an upper midline 
extension through which the xiphoid process is excised (Figure 
13). The midline extension with xiphoid removal provides badly 
needed exposure for dissect i on of the hepatic 1 i gam en ts and the 
suprahepatic inferior vena cava. If it is obvious that there 
will be a struggle to remove the liver, another extension should 
be made immediately into the right seventh intercostal space 
(Figure 13). This is most commonly needed if the liver is 
unusually shrunken. 
Uncomplicated Transplantation 
The pre-existing pathologic changes often necessitate devia-
tions from a standard plan. However, the usual first step is to 
find the hilum to encircle it (Figure 14), and to dissect the 
proper and common hepatic artery in the same way as described for 
the donor (Figure 5). If the artery is of inadequate size, it 
should be mobilized proximal to the gastroduodenal and right 
gastric artery. In difficult cases, the proper hepatic artery 
can be ligated at this time. This can expedite dissection of the 
other hilar structures and slow hemorrhage from the liver surface 
la ter in the procedure. During the hilar dissection, the bile 
duc t (i f one is present) is transected as high as poss i ble so 
tha t the opt i on of duc t to duc t anastomos isis retai ned. The 
portal vein is left intact until later in order not to aggravate 
the portal hypertension. 
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The inferior vena cava below the liver is encircled with as 
little dissection as possible. The left triangular and falciform 
• ligaments are incised until the suprahepatic vena cava can be 
identified. The suprahepatic vena cava is encircled, usually 
from the left side with enough dissection to allow the placement 
of a cross clamp. In some cases, the encirclement may be easier 
from the right side. If these maneuvers can be successfully 
executed, the safety of subsequent steps is increased since, in 
the event of an accident, such as a laceration of the vena cava, 
the liver can be removed from the circulation by emergency cross-
clamping of the encircled but intact vessels. 
In straightforward cases, the" right triangular and cll~onary 
llgaments are incised and the bare area is entered. With retrac-
tion of the liver t01.-lard the left, it becomes safer to dissect 
lengths of the inferior vena cava above and below the liver (Fig-
ure 9). If the native disease is an "easy" one (primary biliary 
cirrhosis for example), adequate cuffs may be obtained wi th the 
liver in place and the mobilization of the entire specimen inclu-
ding ligation of the right adrenal vein can be completed now in 
the same way as with donor hepatectomy (Figures 7-9). If this is 
feasible the time of later portal and vena caval cross-clamping 
is only that necessary to transect the vessels and suture in the 
new liver. The upper vena caval cuff can be fashioned at the 
entry of the main hepatic veins (Figure 15). If the clamp is 
placed'too superior, it is possible to crush the right phrenic 
nerve (Figure 16). 
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This phase of the operation often is not easy because of 
scarring and anatomic distortion above and below the liver and in 
• 
the retrohepa tic area. In patients with cirrhosis, it may be 
impossible to enter the bare area without causing a lethal hemor-
rhage. Then the step of liver isolation described earlier may be 
necessary, with the clamping of the residual hilar structures and 
the previous encircled vena cava above and below the liver. When 
this has been done, the Ii ver including the retrohepatic vena 
cava can be peeled out of the hepatic fossa from below (Figure 
17) or from above (Figure 18). Cu ffs of the suprahepa tic and 
infrahepatic vena cava can be fashioned as the liver is re-
moved. Sufficient infrahepatic 
, I 
vena cava is not difficult to 
obtain, but the development of an adequate suprahepatic cuff may 
require considerable tailoring of the vena cava which is mobil-
ized from within the liver (Figure 18). The technique of isola-
ting the Ii ver in this way and peeling it out in the bloodless 
state permits all residual tissue connections of the right tri-
angular 1 i gament and the bare area, inc 1 ud i ng the right adrenal 
ve in, to be 1 iga ted under perfect vis ion. The penal ty is an 
increased time of portal and vena caval occlusion, which if 
excessive can set into motion an irreversible spiral of 
physiologic deterioration (see later). 
With the liver out, the wound is checked for major sites of 
bleed ing, real i zing that total hemostas i s of the bare area and 
elsewhere is not possible at this time. The suprahepatic and 
infrahepatic vena caval anastomoses are performed first, followed 
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usually by recons truct i on of the portal vei n. At a convenient 
time, air and the potassium rich preservation fluid in the graft 
• 
should be washed out (Figure 19) to prevent air embolism or hy-
perkalemia with revascularization. An al ternati ve to the infu-
sion technique shown in Figure 19 is to flush the liver with the 
fi rst surge of restored portal blood, allowi ng the outflow to 
escape through a vent in the lower caval anastomosis before re-
leasing the upper caval clamp. 
Portal blood flow is usually restored first. After checking 
for major anastomotic leaks, the hepatic arterial anastomosis is 
performed (F igure 20). Frequently, the new liver is at first 
swollen and hard, and there is diffuse hemorrhage from all raw 
areas. Wi th time and the administration of platelets and fresh 
frozen plasma, the problems are usually reversible providing a 
major bleeder has not been mi ssed. Efforts at mechanical hemo-
stasis are continued until it is thought safe to perform the 
biliary tract reconstruction. 
Notations About Vascular Anastomoses 
The back wall of both vena caval anastomoses and that of the 
portal vein must be sutured from the inside. Attempts to develop 
long enough cuffs for external suturing may be frui tless on one 
hand, or if successful, the reconstructed vessels may kink from 
the excess i ve length. We have used a continuous intraluminal 
suturing technique. 
The pr i nc i pIe of the method, as demonstrated in Figure 21, 
is the immed ia te format i on of i ntralum i nal shoulders in both 
vessels to be joined. First, sutures are placed in the extremi-
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ties of the anastomosis. The swaged needle is passed into the 
posterior part of the lumen of one of the vessels one mm from the 
line of incision (Figure 21, A2). • A firm bite of the other ves-
sel is then taken, making sure that the entry and exit sites of 
the needle pass through the intima at some distance from the cut 
edge (Figure 21, A3). The full thic~ness of the wall is inclu-
ded. The same kind of bite is taken in the back wall of the 
other vessel. A mound of protruding tissue presents which makes 
easy the similar placement of subsequent sutures (Figure 21, 
A4) . The back wall is automatically everted. When the opposite 
end of the posterior anastoJ110tic line is reached, the needle is 
passed outside (Figure 21, A4) and the anterior row is completed 
with an everting over and over suture (Figure 21, AS). The steps 
are almost exactly the same for an end-to-end (Figure 21, B) or 
end-to-side anastomosis (Figure 21, C). 
The degree of eversion obtained in the back wall is the same 
as if the sewing were done from the outside (Figure 21, A6). 
Consequently, the amount of intraluminal suture material is not 
increased. There are other advantages. A perfect i nt imal co-
aptation can be assured. If the orifices of tributaries to the 
anastomosed vessels are identified near the suture line, they can 
be incorporated into the shoulder, thereby circumventing poten-
tial para-anastomotic leaks. Gentle traction on the suture fa-
ci I i ta tes placement of the next bi te, making it unnecessary to 
grasp or manipUlate the vessel wall with forceps. 
In the early years of our experience, silk was used for the 
vascular suturing. More recently we have preferred prolene, a 
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material which causes little advential pull, but which can purse 
string an anastomosis because of its easy movement through su-
• 
tured tissues. A minor purse string effect at the large vena 
caval anastomosis has not been a concern but special precautions 
in addition to avoidance of excessive tension on the suture are 
taken to protect the portal vein and hepatic artery. Half of the 
continuous anastomosis is performed with one suture (Figure 22-
2), and its mate is used for the other half of the circumference 
(Figure 22-3). The 2 are tied where they meet, but the knots are 
set at a distance from the vessel of about a third of the circum-
ference (Figure 22-3). When blood flow is restored, the slippery 
prolene pulls back into the suture line and the slack gradually 
is distributed back toward the opposite end (Figure 22-4). The 
process can be encouraged by gentle ciccular knc:3.ding of the 
anastomosis. Any bleeding from resulting gaps in the anastomosis 
is controlled with additional simple sutures. 
The extra suture material has been referred to as a "growth 
factorl1. Some observers have been aghast at this seemingly here-
tical technique until they see the astounding way that small 
anastomoses expand (Figure 22-4), and with little bleeding. 
Pos topera t i ve anastomot ic hemorrhage has not been seen. The 
growth factor technique is used for the hepatic arteries and 
portal-venous anastomoses in all patients. In pediatric recip-
ients, we believe it to be at least as important as the use of 
loupe 'magnification in the routine ability to reconstruct these 
tiny structures at the hepatic hilum. 
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The Question of Venous Bypasses 
Portal and vena caval occl us i on dur i ng the anhe pa tic phase 
• 
often is reasonably well tolerated during a 45 to 90 minute an-
hepa tic phase in sp i te of maj or dec 1 i nes in card i ac output and 
variable hypotension. The relati ve safety of the occlusions 
depends on the collaterals that develop with human liver dis-
ease. The same thing has been demonstrated in dogs subjected to 
chronic bile duct obstruction. Because of this we abandoned the 
venous bypasses which we had used in all of our first cases. 
However, some patients can be gravely jeopardized by the 
venous cross clamping. If severe hypotension occurs after cross 
clamping, CaIne has recommended femoral vein to femoral artery 
bypass with an interv~ning oxygenator. About 10% of the English 
patients are so treated. One death during the last year in our 
series could have been avoided by this precaution as well as a 
cardiac arrest which was successfully treated. 
The fact that most patients can recover from portal and vena 
inferior caval cross clamping may have created a false impression 
about the safety of this practice. Usually there is gross swel-
ling of the intestine during the period of portal occlusion. 
Subsequently, many such pat ien ts suffer from thi rd space flu i d 
sequestration, and from postoperative renal failure. The extent 
to which these complex physiologic events have ~ontributed to the 
high perioperative mortality of liver transplantation has not yet 
been delineated. For this reason we have returned in 1982 to the 
practice of venous bypass which we abandoned long ago. Cannulae 
were placed into the infer ior vena caval (through an iIi ac or 
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femoral vein) and into the portal system through the open end of 
the transected portal vein. During the anhepatic phase the blood 
• 
was returned to a reservoir, and pumped to one of the large veins 
in the neck or arm. This kind of bypass required total body 
heparinization and the amount of bleeding was so excessive and 
nonresponsive to later protamine reversal that 2 of the patients 
died on the operating table. 
Eventually, the feasibility of using pump driven venous by-
passes with no heparin was proved in dogs, using heparin coated 
tubing and non-traumatic closed-system pumps wi thout a reser-
voir. Clinical application was promptly undertaken and now this 
, I 
technique is used for all adult recipients. Wi th this change, 
liver transplantation has become possible with maintenance of 
better patient physiology and without so much stress on the anes-
thesiologists and surgeons. Removal of the devascularized liver 
in a meticulous and delibrate way as well as more leisurely per-
formance of the vascular anastomoses for the first time has made 
transplantation a pleasant operation instead of a desperate race 
against the clock. 
Variant Technical Problems and Solutions 
The "Frozen" liver hilum - - - Patients with previous opera-
tions may have such severe right upper quadrant adhesions that it 
is virtually imposs i ble to enter the abdomen. In such rec i p-
ients, it is essential with sharp dissection to develop an exact 
plane on the undersurface of the li ver, and eventually to en-
circle the portal triad (Figure 14). If the lesser omental sac 
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can be found and entered, through the avascular gastrohepatic 
ligament, the encirclement usually is easiest from the left 
side. If it is then impossible to dissect the individual st~c-
tures of the portal triad, the triad mass can be transected after 
placement of a vascular clamp (Figure 23). The individual struc-
tures can be i den t i f i ed at the cut. sur face and traced back for 
the development of cuffs. 
Arterialization of graft anomalies - Problems posed by 
homograft arterial anomalies (Figure 4) have been described with 
var i ous techn i cal solut ions. A double arteri al supply or i g i na-
ting from the celiac axis and superior mesenteric artery once was 
thought to be too troublesome to ",arrent an effort at reconstruc-
t i on. 'In several recent cases, the cel i ac ax i s and super i or 
mesenteric artery have been connected (Figure 24), and one or the 
other end of the superior mesenteric artery has been anastomosed 
to the recipient hepatic artery. 
Inadequate recipient art~ - Contingency plans should 
be made in the event that a recipient hepatic artery is too small 
or too inconveniently located to permi t an effecti ve anastomo-
sis. The most common cause for this circumstance is an anomolous 
recipient arterial supply such as that described in previous 
sections. 
In our earliest experience in such recipients, attempts were 
made to perform an anastomosis of the graft aorta or celiac axis 
to the aorta of the recipient above the recipient celiac axis. 
The dissection required to clean off the recipient aorta in this 
inaccessible area was difficult, and aortic cross-clamping which 
--- ----- -----------------------------
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was usually required during the anastomosis had devastating phys-
io10gic effects. Consequently this approach has been abandoned . 
• The easiest solution is to attach the homograft blood supply 
to the recipient abdominal aorta, inferior to the origin of the 
renal arteries (Figure 25). The exposure of the distal aorta is 
re 1a t i ve 1y easy, even in pat i en ts wi th severe portal hyperten-
sion. The ascending colon is retracted to the left. The most 
convenient site for anastomosis is near the origin of the infer-
ior mesenteric artery. The extra length of graft vessel neces-
sary to reach this location can be provided by retaining the 
thoracic aorta of the donor in continui ty wi th the ce1i8c axis 
and by turning the aorta 180 degrees"(Figure 25). The occasional 
need for this technical deviation has prompted the donor team to 
retain the thoracic aorta with the specimen whenever possible. 
Another option to obtain the needed length is to anastomose 
the free common iliac artery graft to the same location in the 
recipient aorta with ligation of the hypogastric artery. The 
external i 1 i ac artery is almost a perfect match for anas tomosi s 
to the graft celiac axis. 
Thrombosed or Hypoplastic portal vein - One of the great 
traged ies of 1 i ver trans plan ta t i on has been the discovery at 
operation of an unsuspected thrombosis or hypoplasia of the por-
tal vein. If effective revascularization of the homograft portal 
vein has not been accomplished, survival has never been ob-
tained. In two patients, the suprarenal inferior vena cava has 
been anastomosed to the graft portal vei n, prov i ding the 1 i ver 
with sys temi c venous inflow as wi th a portacaval transpos i tion. 
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This anastomosis thrombosed in one patient who died of massive 
hemorrhage from esophogeal varices a month later, and the other 
patient died of massive graft necrosis. • 
If the thrombosis (or hypoplasia) has not involved the 
splen i c and super ior mesen tel" ic ve i ns, the confluence of these 
portal tr i bu tar i es can be di ss ec ted free from beneath the pan-
creas. We have then developed a cloaca at this junction to which 
an iliac vein graft has been anastomosed to provide added 
length. The use of an interposition host graft under these cir-
cumstances (Figure 12) has been life saving. 
If thrombosis of the portal vein has been recent, thrombo-
phlebectomy has been accomplished on several occasions. Although 
a rough intimal surface has been left, the portal venous system 
hdS remained open. 
Biliary Tract Reconstruction 
In the early days of liver transplantation, the now 
abandoned procedure of cholecystoduodemostomy was frequently used 
(Figure 26, E). Obstruction at the homograft cystic duct occured 
in almost half of the cases. Even without obstruction the 
biliary tract became the site of entry of bacteria (Figure 27). 
Organisms which could be cuI tured from the blood stream were 
those indigenous to the gastro-intestinal tract. It was 
envisioned that the liver was being frequently contaminated with 
enteric contents, followed by systemic dissemination of the 
bacteria (Figure 27). 
The systematic use of a defunctionalized jejunal limb (Roux-
en-Y) to which the gallbladder was anastomosed (Figure 26, F) was 
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an improvement. However the problem of cystic duct obstruction 
in more than 1/3 of the recipients remained (Figure 28), neces-
sitating frequent secondary revisions with conversion to cho·le-
dochojejunostomy (Figure 26, B). 
If biliary enteric anastomosis is necessary, we now perform 
a choledochojejunostomy (Roux-en-Y) at the first operation (Fig-
ure 26, B). This is done with a single layer of continuous ab-
sorbable suture (Figure 29). A few tacking sutures can be used 
for reinforcement (Figure 29). An internal stent is used (Figure 
26, B). When choledochojejunostomy is performed, the gallbladder 
is removed. 
Biliary tract reconstruction bi duct to duct anastomosis was 
the first one used by us and then temporarily abandoned because 
of a high incidence of biliary leaks which were lethal in t~e 
patients treated 15 to 20 years ago. The duct to duct anastomo-
sis (Figure 26, A) is performed with interrupted absorbable su-
tures. AT-tube stent is used whenever possible (Figure 26, A), 
and the T limb is brought out through a choledochotomy in the 
recipient portion of the composite duct. In small children, and 
occasionally adults, the available T-tubes are too large and an 
internal stent is used with the distal tip passed into the duo-
, 
denum (Figure 26, A ). 
In 1973, Waddell and Grover recommended that the homograft 
duct be anastomosed to the graft gallbladder as part of the bil-
iary re'construction in liver transplantation. CaIne has used 
this technique extensi vely in the Cambridge program and for him 
it is the method of choice. The distal anastomosis wi th the 
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fundus of the homograft gallbladder is made either to the recip-
ient common duct (Figure 26, C) or to a Roux limb of jejunum 
• (Figure 26, D). In either case, both of the anastomoses are 
stented with aT-tube which can be used for irrigation. We have 
used the \-/adde II-CaIne procedure only when the extra length 
provided by the gallbladder was necessary to bridge a gap between 
the graft and the distal anastomosis. 
In our hands, choledochocholedochostomy and choledochojejun-
ostomy have both provided excellent results. Our experience with 
the Waddell-CaIne procedure has been too limited to warrant com-
ment, but the Cambridge team has been pleased with the results. 
, I 
Control of Hemorrhage 
The most important factor in hemorrhage is portal hyperten-
sion with extensive venous collaterals. In addition, coagulation 
defects must be anticipated routinely with depletion of clotting 
factors produced by the 1 i ver. In addition, fibrinolysis may 
begin shortly before the revascularization of the homograft and 
assume crisis proportions shortly afterwards. 
Control of bleeding must start with the mechanical means of 
ligation, suture ligation and cautery. With the new liver in 
place, there is decompression of the portal system through the 
new organ wi th elimination of the adverse mechanical factor of 
portal hypertension. If the liver functions well, the perturba-
tions in clotting can be expected to self correct but this may 
, 
requ ire hours. In the meanwhile platelets, fresh frozen plasma 
and blood constituents may be used as a temporary expedients. 
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POSTOPERATIVE CARE 
The commonest early difficulties have been wi th pulmonary 
• i nsuffi c i ency requ i ring prolonged mechani cal vent i la ti on, renal 
failure at the same time that massive fluid shifts are occurring, 
and persistent clotting Rbnormalities. These problems are man-
aged with conventional methods of intensive care with great em-
phasis on biochemical and hemodynamic monitoring. Recovery can 
be expected from preexisting encephalopathy and the hepatorenal 
syndrome. Patients who have received well functioning livers can 
have an almost miraculous recovery, but defective performance by 
the graft at the outset may preclude recovery unless another 
organ can be quickly found for retransplantation. 
IMMUNOSUPPRESSION 
All of the methods to prevent or reverse rejection of whole 
organs have been developed wi th the simpler procedure of renal 
transplantation. These are summarized in Table 4, with a nota-
tion about their use in liver recipients. 
Although there was wide-spread discontent with all tech-
niques of immunosuppression available from 1963 to 1978, improved 
drug therapy was not possible until the advent of cyclosporine. 
Cyclosporine is an extract from the fungus Cylindrocarpon lucidum 
and Trichoderma polysporum. It was discovered and characterized 
b i ochemi cally by sc i ent i s ts at the Sandoz Corpora t i on, Basel, 
Switzerland, who showed it to be immunosuppressive in mice, rats 
and guinea pigs. The drug depressed humoral and cellular immuni-
ty with a quickly reversible action. These effects were not 
accompanied by the bone marrow depression which had frequently 
limited the doses of azathioprine and cyclophosphamide. 
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When cyclosporin A was first used in patients by CaIne of 
Cambridge it was hoped that no other drug would be routinely 
required. • Our experience has been that cyclosporine should be 
combined with steroid therapy from the outset although the ster-
oid component with this version of double drug therapy has been 
smaller than in the past. 
Nephrotoxicity is the most serious side effect of cyclospor-
ine (Figure 30). Fortunately the renal complications are prompt-
ly r'eversed wi th the reduction of the cyclosporine doses. Host 
of the other side effects of cyclosporine have not been serious, 
including hirsutism, gum hyperplasia, tremor, regional flushing 
or vague abdominal discomfort just~fter drug ingestion, and the 
development of breast fibroadenomas in women. Although hepato-
tox i city has been seen in about one fi fth of cases, th is has 
rarely been serious and it can be controlled by dose reduction. 
For 1 i ver transplanta t i on, cyclospor i ne is started a few 
hours pre opera t i vely wi th an oral dose of 11.5 mg/Kg (F igure 
30). Cyclosporine is continued daily, but wi th reduced intra-
muscular or intravenous (Figure 31) quanti ties until diet is 
resumed. Subsequently an oral dose of 17.5 mg/Kg/day is given, 
usually wi th half every 12 hours. The doses are reduced subse-
quently if nephrotoxicity develops. Steroids also are started on 
the day of operation. For adult patients who leave the operating 
room in relatively good condition a 5 day burst of prednisolone 
is given, starting at 200 mg and stopping with a maintenance dose 
of 20 mg per day. Further reductions of cyclosporine and steroid 
doses are made on an individualized basis in the ensuing 
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months. Initial maintenance therapy with steroids is scaled down 
in infants and children (Figure 30). 
• If rejection occurs in spite of this beginning therapy, the 
principal responses have been to administer intermi ttent large 
doses of hydrocortisone (or prednisolone) intravenously (Figure 
31), 'to repeat the original 5 day burst of steroids (Figure 31), 
'-
and to settle at a higher maintenance level of steroids. Al-
though cyclosporine is not a drug which permits much dose maneu-
verability, it has sometimes been possible to increase the a-
mounts given, the limiting factor being nephrotoxicity. Dose 
adjustments of cyclosporine can be aided by pharmacologic moni-
toring of plasma or blood levels. .. 
RESULTS AFTER LIVER REPLACEMENT 
The introduction of cyclosporine-steroid therapy has had a 
major influence upon the results after orthotopic liver trans-
plantation. 
Before Cyclosporine (1963-1979) 
During this time, from 1963-1979, 170 patients underwent 
orthotopic Ii ver transplantation under conventional double drug 
or triple drug therapy. The one year survi val ranged between 
28.8 and 50 % throughout this time, but without an identifiable 
trend of improvement. The results during this 16 year period are 
summarized in Figure 32. 
Of the 170 patients entered into this series, 56 lived out 
the first postopera t i ve year. Twenty-three subsequently died. 
Although 13 of the 23 late deaths were in the second post opera-
tive year losses occurred as late as 6 years. Of the original 
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170 patients, 33 (19.4%) are still alive after followups of 3 1/2 
• 
to 13 1/3 years. Between 1963 and 1979, there was an almost 
equal division between adult and pediatric recipients (Tables 1 
and 2). From the sixth month onward the younger patients had 
about a 10 % survival advantage. 
A similar experience of occasional spectacular successes 
interspersed with a larger number of failures was also heard in 
the Cambr i dge-Ki ng I s College tr ials from the beg i nn ing of that 
program in 1968 through early 1980. In the English series, 22 
(23.7%) of the first 93 recipients lived for at least one year, 
"' 
wi th 11 subsequent deaths d ur i ng the second to sixth years ; at 
the time of last reporting the 11 survivors had been followed for 
1 to 6 years. 
The Cyclosporine Era (1980-1982) 
The predictability and reliability with which liver trans-
plantation could be carried out improved abruptly with the first 
trials of cyclosporine-steroid therapy, and this promise has been 
sustained with subsequent experience. Since 1980, the majority 
of liver recipients have been brought through the early postoper-
ative convalescence and have been able to leave the hospital for 
out-patient care (Figure 32). 
The survival in the first 67 consecutive recipients in the 
cyclosporine era is summarized in Figure 32 and contrasted with 
the pooled previous experience. All of the cyclosporine patients 
in Figure 32 had their operations before 1 May 1982, and thus 
have minimum one year followups. The one year and subsequent 
survival was doubled overnight compared to past expectations. 
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Of the first 67 recipients in the cyclosporine series trea-
• l,;d over a period of more than two years, 42 passed the one year 
HI:irk. Th i s was a lmost as many surv i vors as had been acqu ired in 
L he nearly 17 preced i ng years. Six of the 42 one year surv i vors 
:;!jbs~quently died. In four the cause of the late failure was 
ft:currence of the original disease (2 hepatic malignancies, 1 
,:/3mple each of Budd-Chiari syndrome and B-virus chronic hepati-
~jsFK The other late deaths were caused by an airway obstruction 
:;(;condary to an upper respiratory infection in one patient, and 
))y complications after retransplantation in a patient whose first 
;j 
~raft was chronically rejected. In spite of these 6 deaths after 
r.lne year, the late decline of the life survival curve has been 
~lower than in past patients who entered the second postoperative 
year under azathioprine and prednisone (Figure 32). 
A natural question would be if these resul ts could be ex-
;,lained by a sudden change in candidacy cri teria or by a dif-
~erence in the diseases for which transplantation was per-
~ormedK Analysis according to the recipient diseases showed that 
~his was not the case. Instead, the results with almost all of 
the diseases were improved (Table 5). This was obvious with all 
0f the diagnoses that contributed heavily to the case material 
~eforeand after the introduction of cyclosporine - - - such as 
~iliary atresia, non-alcoholic cirrhosis, primary hepatic malig-
'ancy, primary biliary cirrhosis, and the heterogenous group of 
;nborn errors of metabolism. 
Wi th these improved results the pace of Ii ver transplanta-
. ion has quickened. Between 1963 and the end of 1979, the av-
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erage yearly case load was not much over a dozen. The number of 
transplantations rose to 30 in 1981 and to 80 in 1982. • In the 
first four months of 1983, 34 Ii ver replacements were done, a 
rate that extrapolates to 100 for this year. 
To be a service, a new surgical procedure must be within the 
capa b iIi ty of more than the occas i onal surgeon. Until 1982, 
virtually all of our liver transplantation procedures over a span 
of 19 years were performed by a single surgeon. During 1982, 40% 
of the procedures were performed by another young faculty member 
or by the fellows and this year this figure has been 70%. 
" The influence of cyclosporine upon survi val in the Cam-
bridge-King's College trials has not yet been clearly defined, in 
part because the drug has not been used regularly and in part 
because it has been started late in most cases after an initial 
course of azathioprine and steroid. Nevertheless, improved re-
suIts have been attributed by CaIne to the better immunosuppres-
sion which they can now provide. 
Steps to Reduce Mortality 
A glance at the life survival curves from the earlier days 
of our experience, or even in recent times (Figure 32) shows that 
the highest priority for improved management is reduction of the 
perioperative mortality. However the fact that the surv ivaI 
curves continue to decline even after 3 or 4 months means that 
. 
strategies to circumvent late mortality will also be important. 
Policy adjustments may have an impact in both periods. 
The way in which the original disease dictates the technical 
d iff i cuI ty of transplanta t i on and thus the early mortal i ty was 
~ ------~----
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Of all the adverse possibilities, accepted in future cases. 
inadequate recipient portal 
for which there usually is 
detect a defective portal 
available. 
vein is the worst and the only one 
not a technical remedy. Means to 
vein with ultra sound are now 
Liver transplantation for postnecrotic cirrhosis in B-virus 
carriers and for patients with hepatic malignancies has resulted 
in disease recurrence in the grafts. There is not yet enough 
ev i dence' to foreclose th is a venue of treatment but it will be 
important for workers in the field to pool data in order to ar-
rive at a concensus. Too many late deaths from recurrence of 
--------------"--"---
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these disease have occurred, a problem that has not been so over-
whelming wi th any of the other disorders that have recurrence 
potential. • 
When a transplanted liver fails ei ther early or late from 
rejection or other causes, aggressive attempts at retransplanta-
tion usually offer the only chance for survi val. One of the 
commonest judgement errors we have made is to hope vainly for 
improvement in hepatic function until the hope of reintervention 
was lost. Despite this, more than 40 patients have undergone 
retransplantation since 1968. Only recently have these efforts 
been encouraging. More than 30 patients treated in 1980-1983 had 
retransplantation a few days to 20 months after primary grafting 
and the majority are surviving with subsequent followups of up to 
11;2 years. 
The performance of retransplantation has usually been sur-
pri singly easy. The procedure has been greatly simplified by 
retaining cuffs from the suprahepatic and infrahepatic vena cava 
and from the portal vein of the first graft. Usually it has been 
necessary to perform the arterial anastomosis proximal to the 
prev i ous site of anas tomos is. Fa i lure to do th is in a recent 
case resulted in thrombosis of the arterial segment retained from 
the failed first graft for anastomosis to the celiac axis of the 
second liver. 
SUMMARY 
During the 20 years since transplantation was first attemp-
ted in humans, the procedure has gone from an experimental to a 
d i ffi cult but therapeu ti c procedure. As the mani fold problems 
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associated with this complex form of care have been resolved, the 
survival after liver replacement has improved to the point where 
two thirds of recipients can now be expected to live through the 
first postoperative year. Within the next 2 or 3 years a natio-
nal network of cooperating centers providing this form of ad-
vanced service can be expected to be in place in the Uni ted 
States. 
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FIGURES 
Figure 1. Technique of auxiliary liver transplantation that provides 
splanchnic venous flow for the homograft. Because of portal • 
hypertension caused by the diseased native liver, splanchnic flow 
will pass preferentially through the homograft. (Starzl TE, (With 
the assistance of CW Putnam). Experience in Hepatic Transplanta-
tion. Philadelphia: WE Saunders, 1969.) 
Figure 2. 99mTechnetium liver scans in a patient whose indication for trans-
plantation was hepatoma. Note progressive invasion of liver 
homograft by tumor beginning at 94 days. The patient died of 
carcinomatosis 143 days posttransplantation. At autopsy, the 
homograft was almost cmpletely'replaced with carcinoma. (Starzl 
TE, (With the assistance of CW Putnam). Experience in Hepatic 
Transplantation. Philadelphia: WB Saunders, 1969.) 
. Figure 3. Alpha-fetoprotein determinations in a 3-year-old child who under-
went transplantation for biliary atresia. A small hepatoma was 
discovered within the operative specimen. The child is now 13 2/3 
years after transplantation. Alpha-fetoprotein determinations 
continue to be negative and she remains free of tumor. 
Figure 4. Anomalies of hepatic arterial supply. (Shaw BW Jr, Hakala T, 
Rosenthal JT, Iwatsuki S, Broznick B, Starzl TE. Combination donor 
hepatectomy and nephr~ctomy and early functional results of 
allografts. Surg Gynecol Obstet 1982;155:321-325.) 
Figure 5. Dissection of the portal triad during donor hepatectomy. A, The 
common duct and the gastroduodenal and right gastric arteries are 
tied and divided. B, The hepatic artery has been mobilized far 
enough so that the anterior surface of the portal vein is 
- 46 -
uncovered. The coronary vein entering the left side of the portal 
trunk, or into the splenic vein as shown, is almost always found; 
this tributary is ligated and divided. C, The portal vein has 
been freed and the celiac axis mobilized. The splenic artery has 
not yet been ligated and divided. When the liver is removed, all 
of the celiac axis is usually retained with the specimen, and it 
may be advisable to include a segment of aorta as well. (Starzl 
TE, (With the assistance of CW Putnam). Experience in Hepatic 
Tcansplantation. Philadelphia: WB Saunders, 1969.) 
Figure 6. Alternative approach to arterial supply of liver. During the 
initial dissection, all the aortic branches except the celiac axis 
~~d superior mesenteric artery are ligated and divided; the latter 
vessel is cut only after it has been shown not to give rise to an 
anomalous hepatic arterial branch. A segment of aorta is usually 
removed in continuity with the celiac axis. (Starzl TE, (With the 
assistance of CW Putnam). Experience in Hepatic Transplantation. 
Philadelphia: WE Saunders, 1969.) 
Figure 7. Exposure and inital dissection of the suprahepatic vena cava and 
its tributaries. This is done by entering the raw area formed by 
divergence of the leaves of the falciform and triangular liga-
ments. A short segment of the left hepatic vein (L. H. V.) is 
usually seen first. (Starzl TE, (With the assistance of CW 
Putnam). Experience in Hepatic Transplantation. Philadelphia: WB 
Saunders, 1969.) 
Figure 8: Retraction of the liver to the left. The bare area of the right 
hepatic lobe has been opened, exposing the adrenal gland. The 
right adrenal vein is ligated and divided. This is usually the 
- 47 -
only posterior tributary to the retrohepatic vena cava. At this 
stage of the dissection the right hepatic vein (R. H. V.) can be 
identified. (Starzl TE, (With the assistance of CW Putnam). • 
Experience in Hepatic Transplantation. Philadelphia: WB Saunders, 
1969.) 
Figure 9. Sweeping behind· the retrohepatic vena cava with a dissecting fin-
ger. This should be possible from the diaphragm to the renal 
veins. If resistance is encountered, it usually indicates the 
presence of extra branches which must be ligated and divided. R. 
a. v. - ligated right adrenal vein. (Starzl TE, (With the assis-
tance of CW Putnam). Experience in Hepatic Transplantation. Phila-
H delphia: WB Saunders, 1969.) 
Figure 10. En bloc infusion of liver and kidneys. Note the infusion cannulas 
in the aorta and splenic veins, and the bleed-off cannula in the 
inferior vena cava. (Shaw BW Jr, Hakala T, Rosenthal JT, Iwatsuki 
S, Broznick B, Starzl TE. Combination donor hepatectomy and ne-
phrectomy and early functional results of allografts. Surg Gynecol 
Obstet 1982;155:321-325.) 
Figure 11. Dissection above the liver. A, Development of suprahepatic vena 
caval cuff. At this stage it is desirable to ligate and divide 
one or more phrenic veins on each side. Extra length can also be 
obtained by dissecting off the diaphragmatic reflection, as is 
being shown. B, Cross sectional appearance of the venous con-
fluence above the liver as it is seen from above. The cloaca is 
, 
formed by the junction of the right and left hepatic veins with 
the inferior vena cava. (Starzl TE, (With the assistance of CW 
- 48 -
Putnam). Experience in Hepatic Transplantation. Philadelphia: WE 
Saunders, 1969.) 
Figure 12. The uses to which aortic, vena caval, and iliac vascular grafts 
have been put in renal (A) and hepatic (B) transplantation. 
(Starzl TE, Halgrimson CG, Koep LJ, Weil R III, Taylor PD. Vas-
cular homografts from cadaveric organ donors. (The Surgeon At 
Work) Surg Gynecol Obstet 1919;149:131.) 
Figure 13. Incisions for orthotopic liver transplantations and for hepatic 
resections, right or left. Note that several extensions may be 
made from the basic right subcostal incision, A to A, that is 
almost always used. More than one of the depicted extensions may 
be required in a given patient': (Starzl TE, Bell RH, Beart RW, 
Putnam CWo Hepatic trisegmentectomy and other liver resections. 
Surg Gynecol Obstet 1915;141:429-31.) 
Figure 14. A, Encirclement of the portal structures preparatory to their 
individual dissection. This can be done either from the right 
side as indicated or from the left through the lesser omental sac. 
B, Spatial relationships of the components of the portal triad. 
(Starzl TE, (With the assistance of CW Putnam). Experience in 
Hepatic Transplantation. Philadelphia: WE Saunders, 1969.) 
Figure 15. Transection of the suprahepatic inferior vena cava. Note that the 
line of incision is kept as close to the liver as possible in 
order to retain the maximum vessel length for subsequent anastomo-
sis. R. h. V. = right hepatic vein; L. h. v. = left hepatic 
vein; I. V. C. = inferior vena cava. (Starzl TE, (With the 
assistance of CW mutn~mFK Experience in Hepatic Transplantation. 
Philadelphia: WE Saunders, 1969.) 
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Figure 16. Probable mechanism of operative injury of the right phrenic nerve 
in several pediatric patients. Note the inclusion of the nerve in 
the bite of the vascular clamp, which has been placed across t~e 
suprahepatic vena cava and which has also included a piece of 
diaphragm. (Starzl TE, (With the assistance of CW Putnam). Ex-
perience in Hepatic Transplantation. Philadelphia: WB Saunders, 
1969.) 
Figure 17. C, Operative field after retrograde liver mobilization. The last 
remaining structure, the suprahepatic inferior vena cava, has been 
clamped above the liver. D, Technique for mobilizing a suitable 
length of suprahepatic vena cava after placement of clamp. In 
adults, this usually involves ~utting away cirrhotic liver tissue 
over the frequently distorted and foreshortened right and left 
hepatic veins. (Starzl TE, Porter KA, Putnam CW, Schroter GPJ, 
Halgrimson CG, Weil R III, Hoelscher M, Reid HAS. Orthotopic liver 
transplantation in 93 patients. Surg Gynecol Obstet 19TS;1~O:4UT-
505.) 
Figure 18. Development of a suprahepatic cuff of inferior vena cava. This 
technique is required most commonly if the native disease is non-
alcoholic or alcoholic cirrhosis. Note that the suprahepatic vena 
cava is encircled and clamped (A) and that length is developed by 
cutting and peeling away the diseased liver tissue and scar (B). 
The eventual cuff usually has a lateral closure of either the left 
(C, D) or right hepatic vein. (Starzl TE, Koep LJ, Weil RIll, 
Halgrimson CG. Development of a suprahepatic recipient vena cava 
cuff for liver transplantation. Surg Gynecol Obstet 19T9;1~9:TS-
77.) 
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Figure 19. Initial steps in the implantation of a new liver. (A), Infusion 
with lactated Ringer's solution in order to wash out the potassium 
rich Collin's solution. (B), Completion of suprahepatic • 
anastomosis. (C), Completion of infrahepatic vena cava anasto-
mosis. Note in Band C the escape of air bubbles which if not 
expelled could lead to air embolism. (Starzl TE, Schneck SA, 
11azzoni G, Aldrete JA, Porter KA, Schroter GPJ, Koep LJ, Putnam 
CWo Acute neurological complications after liver transplantation 
with particular reference to intraoperative cerebral air embolus. 
Ann Surg 1978;187:236-240.) 
Figure 20. Completion of vascular reconstructions at hilum, and duct to duct 
biliary anastomosis over a q-tu~ stent. (Starzl TE, Marchioro 
TL, Huntley RT, Rifking D, Rowlands DT Jr, Dickinson TC, Waddell 
WH. Experimental and clinical homotransplantation of the liver. 
Ann N Y Acad Sci 1964;120:739-65.) 
Figure 21. Technique of intralQminal everting vascular suture. A, Side-to-
side; B, end-to-end; and C, end-to-side. (Starzl TE, Groth CG, 
Brettschneider L. An everting technique for intraluminal vascular 
suturing. Surg Gynecol Obstet 1968;127:125-26.) 
Figure 22. Method of avoiding strictures of small vascular anastomoses. 
(Starzl TE, Iwatsuki S, Shaw BW Jr. A "Growth Factor" in fine 
vascular anastomoses. Surg Gynecol Obstet (in press). 
Figure 23.- Incision en masse of the portal triad. This maneuver has been 
necessary on several occasions when the individual structures 
could not be dissected free. After the transection, the portal 
vein and hepatic artery can be liberated enough to permit the 
vascular anastomoses to be performed. (Starzl TE, (With the 
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assistance of CW Putnam). Experience in Hepatic Transplantation. 
Philadelphia: WB Saunders, 1969.) 
Figure 24. The management of a common graft anomaly in which part of the • 
liver blood supply is derived from the superior mesenteric ar-
tery. Note that the celiac axis is anastomosed to one end of the 
main superior mesenteric artery and the other end is used for . 
anastomosis to a recipient vessel. (Shaw BW Jr, Iwatsuki, S, 
Starzl TE. Alternative methods of hepatic graft arterialization. 
Surg Gynecol Obstet (in press). 
Figure 25. Technical solution if an adequate recipient artery cannot be found 
in the area of the portal triad. A piece of graft aorta in con-
tinuity with the graft celiac ~is can be anastomosed to the 
abdominal aorta of the recipient. Alternatively an iliac artery 
graft can be attached to the recipient aorta with a distal anasto-
mosis to the celiac axis. The latter technique depends upon the 
availability of contingency grafts procured at the time of the 
liver harvest (Figure 12). (Shaw BW Jr, Iwatsuki, S, Starzl TE. 
Alternative methods of hepatic graft arterialization. Surg Gyne-
col Obstet (in press). 
Figure 26. Methods of biliary tract reconstruction that have been used with 
liver transplantation. Toe techniques shown in E and F are so 
defective that they have been abandoned. Depending upon the 
anatomic and clinical circumstances, each of the other methods may 
be useful in individual cases. 
Figure 21. Development of regional and systemic infectious complications 
secondary to contamination and/or partial obstruction of the 
biliary tract. (Starzl TE, Groth CG, Brettschneider L, Penn I, 
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Fulginiti VA, Moon JB, Blanchard H, Martin AJ, Porter KA. Orthoto-
pic homotransplantation of the human liver. Ann Surg 1968;168:392-
415.) • 
Figure 28. Transhepatic cholangiograms in four patients whose original bil-
iary reconstructions were with Roux-en-Y cholecystojejunostomy. 
(A), minimal obstruction; (B), moderate obstruction; (C), 
severe obstruction with leak and abscess formation; (D), very 
severe obstruction; at reoperation the common duct was necrotic. 
(Key to abbreviations: A = leak and abscess formation; C = common 
duct; CD = cystic duct; GB = gallbladder; J = jejunum; large arrow 
= site of common duct ligation). (Starzl TE, Putnam CW, Hans-
brough JF, Porter KA, Reid HAS'. Biliary complications after liver 
transplantation; with special reference to the biliary cast syn-
drome and techniques of secondary duct repair. Surgery 
1977;81:212-21.) 
Figure 29. Technique of choledochojejunostomy. (Starzl TE, Putnam CW, 
Hansbrough JF, Porter KA and Reid HAS. Biliary complications after 
liver transplantation: with special reference to the biliary cast 
syndrome and techniques of secondary duct repair. Surgery 
1977;81:212-21.) 
Figure 30. Immunosuppression with cyclosporine and steroids (plus temporary 
azathioprine) in a 10-year-old girl (OT 193). Note that the 5-day 
opening burst of prednisone therapy was scaled down because of her 
small size. The temporary discontinuance of cyclosporine and 
replacement with azathioprine between postoperative Days 10 and 15 
was because of probable cyclosporine nephrotoxicity. The patient 
who vias of B blood type was given the liver of an A donor. 
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(Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, 
Malatack JJ, Schade RR, Shaw BW Jr, Hakala TR, Rosenthal JT, 
Porter KA. Evolution of liver transplantation. Hepatology • 
19UO;O:S1~-PSKF 
Figure 31. Deviation from standard steroid therapy in a patient (aT 219) 
whose perioperative condition was frail. The 5-day burst of 
postoperative steroids was begun several days postoperatively but 
had to be repeated when rejection supervened. Before operation, 
the patient had hepatorenal syndrome and encephalopathy and he had 
been on a ventilator for more than 1 week. Because of defective 
clotting, efforts to place central venous lines before starting 
;j 
transplantation resulted in uncontrolled hemoI'rhage with the loss 
of 20 liters of blood. The subclavian and innominate vessels were 
explored through cervical and thoracotomy incisions, and the 
bleeding was mechanically controlled before transplantation was 
started. The blood loss from placement of the vascular lines 
exceeded that incurred during transplantation. The patient sur-
vived because of prompt correction of the coagulation abnormali-
ties. (Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli 
BJ, Malatack JJ, Schade RR, Shaw BW Jr, Hakala TR, Rosenthal JT, 
Porter KA. Evolution of liver transplantation. Hepatology 
19UO;O:S1~-PSKF 
Figure 32 •. The survival of 67 patients treated with cyclosporine and low dose 
steroids (minimum follow 16 months) compared to the survival ob-
tained under conventional linmunosuppression (azathioprine). 
(Starzl TE, Iwatsuki S, Van Tniel DH, Gartner JC, Zitelli BJ, 
VBlatack JJ, Schade RR, Shaw BW Jr, H8kala TR, Rosenthal JT. 
Report of Colorado-Pittsburgh liver transplantation studies. 
Transplant Proceedings In press.) 
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